Core Viewpoint - Rosen Law Firm is reminding purchasers of Semler Scientific, Inc. securities about the lead plaintiff deadline for a securities class action lawsuit, emphasizing the potential for compensation without upfront costs for eligible investors [1][2]. Group 1: Class Action Details - The class action pertains to securities purchased between March 10, 2021, and April 15, 2025, with a lead plaintiff deadline set for October 28, 2025 [1]. - Investors who wish to join the class action can do so through a provided link or by contacting the firm directly [3][6]. - A class action lawsuit has already been filed, and interested parties must act by the specified deadline to serve as lead plaintiff [3]. Group 2: Legal Background - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The claims suggest that the defendants' public statements were misleading, leading to investor damages when the true information became public [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4].

Core Insights - McKesson (MCK) is valued at $100.9 billion and operates in healthcare services and information technology across four segments [1] - The stock has shown strong technical momentum, gaining 9.12% since a "Buy" signal was issued on September 23 [2] - McKesson has reached an all-time high of $811.86 in intraday trading on October 27 [4] - The stock has a 100% "Buy" opinion from Barchart, with shares up nearly 60% over the past year [6] - Analyst sentiment is positive, with price targets reaching up to $984 despite some valuation concerns [6] Technical Indicators - McKesson has a Weighted Alpha of +52.53 and a Relative Strength Index (RSI) of 70.21 [7] - The stock recently traded at $810.29, with a 50-day moving average of $734.34 [7] - There is a technical support level around $803.12 [7] Financial Projections - Revenue is projected to grow by 13.88% this year and an additional 8.26% next year [8] - Earnings are estimated to increase by 16.00% this year and another 13.37% next year [8]

Core Insights - Three stocks with strong growth characteristics and buy ranks are highlighted for investors: Universal Health Services, Micron Technology, and Skillsoft [1][2][3] Company Summaries - **Universal Health Services (UHS)**: - Operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers - Holds a Zacks Rank 1 (Strong Buy) - Zacks Consensus Estimate for current year earnings increased by 0.7% over the last 60 days - PEG ratio of 0.86 compared to the industry average of 1.02 - Growth Score of A [1][2] - **Micron Technology (MU)**: - A leading provider of semiconductor memory solutions - Holds a Zacks Rank 1 - Zacks Consensus Estimate for current year earnings increased by 24.3% over the last 60 days - PEG ratio of 0.48 compared to the industry average of 1.32 - Growth Score of A [2] - **Skillsoft (SKIL)**: - Provides digital learning, training, and talent solutions - Holds a Zacks Rank 1 - Zacks Consensus Estimate for current year earnings increased by 240.9% over the last 60 days - PEG ratio of 0.49 compared to the industry average of 0.88 - Growth Score of B [3]

Core Viewpoint - Auna S.A., a Latin American healthcare company, is planning to offer senior secured notes in a private offering to qualified institutional buyers under Rule 144A of the Securities Act of 1933 [1] Group 1 - Auna S.A. operates in Mexico, Peru, and Colombia [1] - The company is collaborating with Oncosalud S.A.C. as co-issuers for the offering of the notes [1]

Core Insights - A guilty plea in a Medicaid fraud case highlights significant healthcare scams costing U.S. taxpayers billions [1] - The fraud involved billing Medicaid for services that were never provided, with one individual admitting to $1.2 million in fraudulent claims [1][2] - The U.S. Department of Justice estimates healthcare fraud costs Americans approximately $100 billion annually, while other estimates suggest it could be as high as $300 billion [3][4] Group 1: Fraud Details - Anwar Adow, through his company Liberty Plus LLC, fraudulently billed Medicaid for care not provided, exploiting the Housing Stabilization Services program [1][2] - Adow's actions included drawing vulnerable clients into the scam to collect personal information for fraudulent billing [2][3] - His brother, Asad Adow, is also implicated, accused of defrauding $2.7 million from Medicaid [3] Group 2: Impact on Healthcare Programs - The scale of fraud has led to the termination of the Housing Stabilization Services program due to widespread abuse [3] - The acting U.S. Attorney emphasized that the current system of oversight is failing, allowing fraud to overshadow legitimate services [2] Group 3: Financial Implications - The U.S. Department of Justice's estimate of $100 billion in annual healthcare fraud is considered conservative, with some experts suggesting the true cost could be significantly higher [3][4] - The National Health Care Anti-Fraud Association estimates that healthcare fraud constitutes 3% to 10% of national health expenditures, translating to around $300 billion annually [4]

Core Viewpoint - Marex Group PLC is facing a class action lawsuit for allegedly misleading investors about its revenue projections and inflating its financial metrics through improper transactions [2][3]. Group 1: Company Overview - Marex Group PLC is a U.K.-based diversified global financial services platform listed on NASDAQ under the ticker MRX [1]. Group 2: Legal Allegations - The lawsuit claims that Marex Group failed to disclose that it improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [3]. - As a result of these alleged actions, investors who sold short Marex Group securities during the class period have reportedly suffered significant losses [3]. Group 3: Class Action Participation - Shareholders who wish to serve as lead plaintiffs in the class action must submit their papers to the court by December 8, 2025 [4]. - Participation in the class action is not mandatory for recovery; shareholders can remain absent class members if they choose not to take action [4]. Group 4: Legal Representation - Robbins LLP, a firm specializing in shareholder rights litigation, is representing the class action on a contingency fee basis, meaning shareholders pay no fees or expenses unless there is a recovery [5].

meeting. Joining us here at Post9 is DWS Group, America's CIO, David Biano. David, thanks for coming in.>> Carl, thanks. >> Interesting action today in that we basically jumped up 60 points and it barely budged in the first couple hours. >> Yeah, it's uh looking like a great October, right.A treat. Um earning season's going well so far. Expecting it to go well for the rest of this week when we get 40% of S&P profits reported.But a day like today, again, the tech, the chip names are stealing everybody's inte ...

Economic Overview - U.S. consumer prices increased by 0.3% in September 2025, slightly down from August's 0.4% gain and below the expected 0.4% growth [1] - Energy costs rose by 1.5%, driven by a 4.1% increase in gasoline prices, while food prices saw a 0.2% increase [1] - The core consumer price index, excluding food and energy, gained 0.2%, just below August's rate and slightly under the forecast of 0.3% growth [1] - The annual consumer price index recorded a rise of 3%, which was less than economists' expectations [1] Sector ETFs & Stocks to Gain Energy Sector - The VanEck Oil Services ETF (OIH) is highlighted as a potential investment, with revenues tied to energy prices, a significant component of inflation indices [3] - Monthly inflation for energy was 1.5% in September, with annual inflation at 2.8% [3] - Murphy USA (MUSA), a leading independent retailer of motor fuel and convenience merchandise, is noted as a good investment opportunity with a Zacks Rank of 3 (Hold) [4] Restaurant Sector - The AdvisorShares Restaurant ETF (EATZ) is actively managed and invests at least 80% of its net assets in companies deriving at least 50% of their revenues from the restaurant business [6] - The food-away-from-home index rose by 0.1% in September, with limited-service meals increasing by 0.2% and full-service meals remaining unchanged [5] - Red Robin Gourmet Burgers (RRGB), a full-service casual dining restaurant chain, is identified as a strong buy with a Zacks Rank of 1 [6] Healthcare Sector - The Health Care Select Sector SPDR ETF (XLV) includes companies from various healthcare industries and is based on the Health Care Select Sector Index [7] - The index for medical care services rose by 3.9% annually and 0.3% sequentially in September [7] - Universal Health Services (UHS), which operates acute care hospitals and other healthcare facilities, is mentioned as a buy with a Zacks Rank of 2 [8] Transportation Sector - The SPDR S&P Transportation ETF (XTN) tracks the S&P Transportation Select Industry Index and has a Zacks ETF Rank of 3 [9] - The transportation index increased by 0.3% sequentially and 2.5% year over year in September [9] - Delta Air Lines (DAL), a major player in the U.S. aviation market, is highlighted as a buy with a Zacks Rank of 2 [10]

Core Viewpoint - HCA Healthcare, Inc. announced that its subsidiary, HCA Inc., plans to offer senior notes, with terms dependent on market conditions at the time of pricing [1] Group 1: Offering Details - The actual terms of the senior notes, including maturity, interest rate, and principal amount, will be determined based on market conditions [1] - The net proceeds from this offering are intended for general corporate purposes, which may include the repayment of outstanding borrowing [1]

Core Insights - HCA Healthcare's revised 2025 outlook appears conservative despite strong third-quarter performance, with analysts noting potential caution in guidance [3] - The company reported a significant boost in adjusted earnings due to finalized Medicaid state supplemental payment programs, contributing $240 million to earnings and driving year-over-year growth in inpatient revenue [4][5] - HCA raised its full-year profit and revenue outlook, expecting revenue between $75 billion and $76.5 billion and net income between $6.5 billion and $6.72 billion for 2025 [8] Financial Performance - HCA's third-quarter revenue reached $19.2 billion, reflecting a 9.6% year-over-year increase, driven by rising same-facility equivalent admissions and higher surgical volumes [8] - Same-facility equivalent admissions increased by 2.4% year over year, while emergency room visits and inpatient and outpatient surgeries saw approximately 1% growth [6] Medicaid and Subsidy Implications - The government funds from Medicaid are crucial for offsetting the gap between reimbursement rates and actual care costs, with HCA relying on these payments [5] - Potential disruptions to enhanced Affordable Care Act subsidies, set to expire at the end of 2025, could lead to millions becoming uninsured and significant revenue losses for providers [7]